SC
NAUT icon

Steven Cohen’s Nautilus Biotechnolgy NAUT Stock Holding History

Steven Cohen’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
67,938
-15,105
-18% -$39.9K ﹤0.01% 3658
2026
Q1 		$322K Buy
83,043
+22,210
+37% +$54.6K ﹤0.01% 3337
2025
Q4 		$119K Buy
+60,833
New +$99.7K ﹤0.01% 3720
2021
Q3 		– Sell
-64,866
Closed -$655K – 1172
2021
Q2 		$655K Sell
64,866
-66,610
-51% -$721K ﹤0.01% 847
2021
Q1 		$1.81M Buy
+131,476
New +$1.82M 0.01% 741

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Steven Cohen's NAUT Position: Q2 2026 in Review

Steven Cohen reduced its Nautilus Biotechnolgy (NAUT) stake by 18% in Q2 2026, selling an estimated $39.9K and leaving 67,938 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #3658.

Steven Cohen first reported a position in NAUT in Q1 2021 and has held it in 5 quarters since. The position peaked at $1.81M in Q1 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Steven Cohen held 67,938 shares of Nautilus Biotechnolgy worth $127K as of Q2 2026.
  • Steven Cohen sold 15,105 Nautilus Biotechnolgy shares in Q2 2026, an estimated $39.9K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3658 holding.
  • Steven Cohen first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 5 quarters since.
  • Steven Cohen's Nautilus Biotechnolgy position peaked at $1.81M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.